You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 67 No. 2, February 1953 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

LOCAL OXYTETRACYCLINE ("TERRAMYCIN") THERAPY OF SKIN INFECTIONS

CARROLL S. WRIGHT, M.D.; DONALD N. TSCHAN, M.D.

AMA Arch Derm Syphilol. 1953;67(2):125-128.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

THE ANTIBIOTIC known as oxytetracycline ("terramycin") is produced from a species of earth mold (Streptomyces rimosus) and as a crystalline amphoteric substance reacting chemically with certain acids or bases to form stable crystalline salts. In contrast to the accidental discovery of penicillin, by Fleming in 1929, the development of oxytetracycline resulted from an organized concentrated search for a therapeutic agent against bacterial, rickettsial, spirochetal, and certain viral and protozoan organisms. The actual program of collecting 100,000 soil samples from a multitude of locations on the various continents of the world has been described by Kane, Finlay, and Sobin.1 It was after a prolonged screening process that an actinomycete, S. rimosus (so called because of the cracked appearance of the growth on agar medium), yielded a new antibiotic.2

Oxytetracycline was first prepared in pure crystalline form by Regna and Solomons.3 The antibiotic occurs as a bright yellow powder, . . . [Full Text PDF of this Article]


Author Affiliations

PHILADELPHIA

From the Department of Dermatology, Temple University School of Medicine.


Footnotes

"Terramycin" for this investigation was furnished by Chas. Pfizer & Company, Inc., Brooklyn.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1953 American Medical Association. All Rights Reserved.